Literature DB >> 21709143

Organized colorectal cancer screening in integrated health care systems.

Theodore R Levin1, Laura Jamieson, Daniel A Burley, Juan Reyes, Michael Oehrli, Cindy Caldwell.   

Abstract

Colorectal cancer (CRC) is an ideal target for early detection and prevention through screening. Noninvasive screening options are the guaiac fecal occult blood test and the fecal immunochemical test. Organized screening offers the promise of uniformly delivering screening to all members of a population who are eligible and due. Organized screening is defined as an explicit policy with defined age categories, method, and interval for screening in a defined target population with a defined implementation and quality assurance structure, and tracking of cancer in the population. The UK National Health Service; the Ontario, Canada Ministry of Health and Long-Term Care; and the US Veteran's Health Administration have used varied organized approaches to deliver guaiac fecal occult blood test screening to their populations. Kaiser Permanente Northern California began CRC screening in the 1960s, initially using flexible sigmoidoscopy. Implementation of organized fecal immunochemical test outreach was associated with improved Healthcare Effectiveness Data and Information Set CRC screening rates between 2005 and 2010 from 37% to 69% and from 41% to 78% in the commercial and Medicare populations, respectively. Organized fecal immunochemical test screening has been associated with an increase in annually detected CRCs, almost entirely because of increased detection of localized-stage cancers.

Entities:  

Mesh:

Year:  2011        PMID: 21709143     DOI: 10.1093/epirev/mxr007

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN: 0193-936X            Impact factor:   6.222


  91 in total

Review 1.  Challenges and possible solutions to colorectal cancer screening for the underserved.

Authors:  Samir Gupta; Daniel A Sussman; Chyke A Doubeni; Daniel S Anderson; Lukejohn Day; Amar R Deshpande; B Joseph Elmunzer; Adeyinka O Laiyemo; Jeanette Mendez; Ma Somsouk; James Allison; Taft Bhuket; Zhuo Geng; Beverly B Green; Steven H Itzkowitz; Maria Elena Martinez
Journal:  J Natl Cancer Inst       Date:  2014-03-28       Impact factor: 13.506

2.  Colorectal cancer deaths attributable to nonuse of screening in the United States.

Authors:  Reinier G S Meester; Chyke A Doubeni; Iris Lansdorp-Vogelaar; S Lucas Goede; Theodore R Levin; Virginia P Quinn; Marjolein van Ballegooijen; Douglas A Corley; Ann G Zauber
Journal:  Ann Epidemiol       Date:  2014-12-05       Impact factor: 3.797

3.  'Simple and easy:' providers' and latinos' perceptions of the fecal immunochemical test (FIT) for colorectal cancer screening.

Authors:  Claudia X Aguado Loi; Dinorah Martinez Tyson; Enmanuel A Chavarria; Liliana Gutierrez; Lynne Klasko; Stacy Davis; Diana Lopez; Tracy Johns; Cathy D Meade; Clement K Gwede
Journal:  Ethn Health       Date:  2018-01-10       Impact factor: 2.772

4.  Evaluating Two Evidence-Based Intervention Strategies to Promote CRC Screening Among Latino Adults in a Primary Care Setting.

Authors:  Sheila F Castañeda; Balambal Bharti; Rebeca Aurora Espinoza-Giacinto; Valerie Sanchez; Shawne O'Connell; Fatima Muñoz; Sylvia Mercado; Marie Elena Meza; Wendy Rojas; Gregory A Talavera; Samir Gupta
Journal:  J Racial Ethn Health Disparities       Date:  2017-06-20

5.  Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue.

Authors:  Theodore R Levin; Douglas A Corley; Christopher D Jensen; Amy R Marks; Wei K Zhao; Alexis M Zebrowski; Virginia P Quinn; Lawrence W Browne; William R Taylor; David A Ahlquist; Graham P Lidgard; Barry M Berger
Journal:  Dig Dis Sci       Date:  2017-01-02       Impact factor: 3.199

6.  Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems.

Authors:  Andrea N Burnett-Hartman; Shivan J Mehta; Yingye Zheng; Nirupa R Ghai; Dale F McLerran; Jessica Chubak; Virginia P Quinn; Celette Sugg Skinner; Douglas A Corley; John M Inadomi; Chyke A Doubeni
Journal:  Am J Prev Med       Date:  2016-04-01       Impact factor: 5.043

Review 7.  Stool Based Testing for Colorectal Cancer: an Overview of Available Evidence.

Authors:  Kevin M Rank; Aasma Shaukat
Journal:  Curr Gastroenterol Rep       Date:  2017-08

Review 8.  The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer?

Authors:  Jeffrey K Lee; Theodore R Levin; Douglas A Corley
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03       Impact factor: 11.382

9.  FITting ADR to colonoscopy indication.

Authors:  C Hassan; A Repici; D K Rex
Journal:  United European Gastroenterol J       Date:  2016-09-20       Impact factor: 4.623

10.  Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates.

Authors:  Jennifer K Coury; Jennifer L Schneider; Beverly B Green; Laura-Mae Baldwin; Amanda F Petrik; Jennifer S Rivelli; Malaika R Schwartz; Gloria D Coronado
Journal:  Transl Behav Med       Date:  2020-02-03       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.